Kristene Diggins, FAANP, CNE, NEA-BC, DNP, DCC, MBA, manager of professional practice at MinuteClinic, talks about the benefits and risks of aggressive glycemic controls.

Latest News

Rachel Lutz
More than half of atrial fibrillation patients discontinue or interrupt warfarin therapy within 1 year of starting treatment.
Differences Between Motivational Interviewing and Traditional Patient Counseling Techniques
Bruce Berger, PhD, president of Berger Consulting LLC, discusses the major differences between motivational interviewing and traditional patient counseling techniques with respect to medication adherence.
Krystle Vermes
Amgen is seeking FDA approval for etelcalcetide, the first calcimimetic agent administered intravenously after dialysis to treat secondary hyperparathyroidism in patients with chronic kidney disease.
Roadblocks to Appropriate OTC Management of URTIs
Erin Dorval, community assistant professor of pharmacy practice at Palm Beach Atlantic University, discusses how pharmacists overcome the challenges of appropriating OTC management of URTIs.
Roadblocks to Controlling Type 2 Diabetes
Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville talks about the biggest roadblocks to controlling type 2 diabetes.
Meghan Ross, Associate Editor
An independent pharmacy will pay a $46,000 settlement over an alleged lack of break times for its employees.
Benefits of Introducing New Technology to Community Pharmacy
Pat Basu, MD, MBA, chief medical officer of Doctor on Demand, discusses the major benefits of introducing new technology to community pharmacy.
Allison Gilchrist, Associate Editor
Pharmacists must prepare for full enforcement of the Drug Supply Chain Security Act (DSCSA) in order to avoid significant penalties associated with noncompliance.
Pharmacy Week in Review: August 28, 2015
This weekly video program highlights the latest in pharmacy news, product news, and more.
Davy James, Managing Editor of Specialty Pharmacy Times, and Meghan Ross, Associate Editor
The FDA today approved evolocumab (Repatha) injection, a new treatment for patients unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.

Trending Now

Pharmacist Education

Educated Patient

If you are receiving radiation and chemotherapy for cancers of the head and neck, you may experience oral mucositis.
Peptic ulcer disease leads to 1 million hospitalizations and 6500 deaths annually.
Dietary supplements are intended to supplement the diet, not to cure, prevent, or treat diseases or replace the variety of foods important to a healthy diet.
Early detection and treatment are key to protecting eyesight.
Previous TabNext Tab
Strategic Alliance Partners
Latest Issues